A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
Live Conference Call and Webcast Scheduled for February 8, 2018, at 4:30 p.m. ETENGLEWOOD, Colo., Feb. 1, 2018 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology,...
Presentation on Tuesday, January 9th at 9:30 AM Pacific TimeENGLEWOOD, Colo., Jan. 2, 2018 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that...
ENGLEWOOD, Colo., Dec. 18, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced the appointment of David A. Green as Chief Financial Officer. Mr....
ENGLEWOOD, Colo., Nov. 28, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on the launch of Natesto in the U.S. Significant Natesto...
ENGLEWOOD, Colo., Nov. 9, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an overview of its business, including the Company's operational and...
ENGLEWOOD, Colo., Nov. 7, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Australian Government Department of Health and Therapeutic...
Live Conference Call and Webcast Scheduled for November 9, 2017, at 4:30 p.m. ETENGLEWOOD, Colo., Nov. 2, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology,...
ENGLEWOOD, Colo., Nov. 1, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that it presented six posters demonstrating the clinical potential...
ENGLEWOOD, Colo., Oct. 26, 2017 -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today provided an update on the ongoing launch of Natesto in the U.S. Through...
ENGLEWOOD, Colo., Oct. 19, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the Company will ring the NASDAQ closing bell on Friday,...